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NEONATAL SCREENING FOR CONGENITAL
HYPOTHYROIDISM IN PAKISTAN
Pages with reference to book, From 282 To 284 
Murntaz Lakhani, Mohammad Khurshid, Shehla H. Naqvi, Mohammad Akber  ( Departments of Paediatrics and Pathology,
The Aga Khan University Hospital, Karachi. ) 
Abstract 
Congenital hypothyroidism is a preventable cause of mental retardation. Since clinical signs of
congenital hypothyroidism do not generally become obvious before three months of age, screening
programmes have been introduced in North America and Europe, which consist of T4 or TSH
screening on newborn infants on the third day of life. The screening for congenital hypothyroidism was
initiated in Pakistan by the Aga Khan University Hospital (AKUH) in March 1987. By April 1988,
5000 neonates were screened and five cases of congenital hypothyroidism were diagnosed. The study
revealed the incidence of hypothyroidism to be one case per 1000 newborns which is about 4 times
more than that in the West (JPMA 39: 282, 1989).
INTRODUCTION 
Association of mental retardation with congenital hypothyroidism was first described in the 15th
century but the horror of cretinism was expressed by Osler in 18971. In the same decade the treatment
of congenital hypothyroidism with thyroid extract was reported. Sixty years after the introduction of
thyroid replacement therapy, it was realised that although the treatment abolished the physical
manifestations of congenital hypothyroidism, “unless it was started within the first few weeks of life
serious intellectual and neurological deficits frequently persisted2”. The pre and post-natal periods are
critical for brain development. Thyroid hormone is essential for the development and growth of brain3-
5
. Autopsies in the human infant with congenital hypothyroidism shows hypoplasia of the cerebellar
and cerebral cortices, edema and incomplete myelination6. Neither T% T4 or TSH cross placental
barrier to any significant degree. The fetal pituitary thyroid axis binctions independently of the
maternal axis, and maternal thyroid hormones do not protect against congenital hypothyroidism. In
1972, Klein and associates7 showed that if the treatment of hypothyroid infants was started before the
age of 3 months, mean 1.0. of patients was 89 whereas it was 70 when treatment was started between 3
and 6 months of age and only 54 if treatment was delayed beyond six months. Early clinical diagnosis
is difficult. Few infants show diagnostic features of hypothyroidism at birth. The early manifestations
are subtle, non-specific and the stigmata of “aggravated creatinism” develop only slowly. For these
reasons, even in the best of circumstances less than half the children with congenital hypo-thyroidism
are identified before three months of age, making the potential benefit of neonatal screening evident. A
preliminary report of mass screening programme from Quebec (Canada) showed a hypothyroidism
incidence of 1/7000 new-borns8. It also showed that radio-immunoassay for detection of T4 in dried
filter paper blood spot was effective in detecting thyroid hormone abnormalities with an acceptable
percentage of false positive measurements and no false negative results. The second International
Conference on Neonatal Thyroid Screening9 indicated a prevalence of primary hypothyroidism to be
aproximately one in 3800 to 4000 infants worldwide9. Screening in North West health region of
England showed a significantly higher incidence of congenital hypothyroidism in Asian families -
1/918 compared with 113391 in non-Asians10. To measure both thyroxine (T4) and thyroid stimulating
hormone (TSH) on all specimen is ideal but expensive. The pros and cons of using either hormone as
primary screen are listed in Table I11. Japan, most of the European countries and some states in North
America are using TSH screening as primary method12. The reported increased incidence of congenital
hypothyroidism in babies born to Asian mothers had initiated our interest in carrying out screening in
Pakistan where the incidence of congenital hypothyroidism is not known:
PATIENTS AND METHODS 
From March 1987 to September 1988, 5000 neonates were screened. All neonates delivered at Aga
Khan University Hospital and 4 maternity homes situated in metropolitan Karachi were included in the
study. Capillary blood samples were collected on 3 circles on the filter paper provided by AKUH labo-
ratory. A questionnaire regarding maternal health was filled before the collection of blood, especially
regarding family history of thyroid disorder. The site chosen to obtain blood was the planter surface of
the toot (Figure).
The area was wiped with 70% alcohol for one minute and allowed to dry. Skin was punctured in one
continuous deliberate motion in a direction almost perpendicular to the puncture site to a depth of about
2.5 mm with a lancet. The first drop of blood was wiped off with a dry sterile swab and then the blood
was collected directly from the heel on to the three circles of the filter paper. After the blood spots had
dried, filter paper was sent to the laboratory. The T4 and TSH levels were measured from the blood on
the filter paper by radioimmunoassay using Coat-A-count Neonatal T4 and TSH double antibody
system by RIA (Diagnostic Products Corporation, Los Angeles, USA). If the specimen was found to
have low T4 and high TSH then the cons centrations of T4 and TSH were confirmed on the venous
sample. The established laboratory normal values ranged from: for capillary spccimens:T4, 6.9-26.4
and TSH, <20,uIU/ml., for venous sam-pies: T4, 4.5- 12.5 ug/dl and TSH 0.3-4.5 uIU/ml.
RESULTS 
Of the 5000 neonates screened, 6% (300) had low T4 and normal TSH, 13% (65) had high TSH but
normalT4,whiie six (0.12%) had lowT4 and high TSH. Six neonates with low T4 and high TSH were
recalled for Venous sampling.
Five out of six were confirmed to have congenital hypothyroidism even on this basis of low T4 and
high TSH level in serum specimen. One neonate had normal T4 but slightly elevated TSH on venous
sampling which could be seen in compensated hypothyroidism. Out of 300 (6%) neonates with low T4
and normal TSH 9 were recalled for Venous sampling 8 out of 9 had normal T4 and TSH in serum. One
infant with very low T4 and normal TSH in serum sample was further tested with T3 resin uptake
which was significantly elevated. This is an indirect evidence of TBG deficiency. Of 65 neonates with
high TSH and nonnalT4, nine were recalled. Eight out of 9 had normal values of T4 and TSH in serum
sample, while one neonate had normal T4 and slightly elevated TSH which is usually seen in cases of
compensated hypothyroidism. Details of five diagnosed cases is given in Table II.
In case I there was a past history treated maternal hypothyroidism. In case V, mother had a large goitre
inspite of thyroidectomy done twice. This neonate at the time of recall already had symptoms of
congenital hypothyroidism which were prolonged neonatal jaundice requiring hospitalisation, severe
constipation and umbilical hernia. In four cases diagnosis were further confirmed radiologically. X-ray
of both knees revealed either absent or rudimentary tibia! and/or femoral epiphy-sis which is an
evidence of delayed bone age in a term infant, an important feature of congenital hypothyroidism.
DISCUSSION 
The objective of a screening programme for congenital hypothyroidism is early detection and treatment
to minimise neurological deficiencies1. This report has revealed four-fold higher incidence of the
disease in the screened population as compared to figures from North America and Europe. This
incidence has been calculated excluding two cases of compensated hypothyroidism. The cause for this
high incidence in our population is not clear. Radioisotope scanning of thyroid gland in these infants
was not possible due to lack of facilities. This would have helped in identifying the etiology.
Nutritional iodine deficiency leading to thyroid disorder is a common problem in the northern
mountainous regions of Pakistan. However, this is not a common clinical problem in the seaside locale
of Karachi. Although the disease is known to be more common in females, in this study there were 3
males and 2 females. Since there is a maternal history of thyroid disorder in two out of five cases,
maternal antibodies may be responsible for this increased incidence but they were not tested. However,
in one case where there was no history of maternal thyroid disorder, maternal serum was tested for
antibodies which was negative. Our study also confirmed the previously described higher rate of false
positive with T4 as compared to TSH testing. Since 90% of the cases of congenital hypothyroidism are
primary in nature, TSH screening will become the future screening measure in our laboratory.
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